Skip to main content
. 2022 Apr 9;22:379. doi: 10.1186/s12885-022-09465-9

Table 4.

Univariate and multivariate analysis of IRGs signature and clinical characteristics with OS

Gene Univariate analysis Multivariate analysis
P value Hazard ratio P value Hazard ratio
BMI 0.037 0.693(0.491–0.979) 0.095 0.718(0.412–1.062)
Age 0.941 0.985(0.670–1.450)
Gender 0.524 1.228(0.652–2.312) 0.088 1.790(0.922–3.518)
Grade 0.933 1.013(0.754–1.360)
Stage 0.014 1.452(1.080–1.952)
Stage T 0.008 1.493(1.110–2.008) 0.064 1.36(0.98–1.89)
IRGs risk score 0.002 2.602(1.437–4.709) 0.022 2.15(1.12–4.13)
Tumor status 0.081 1.652(0.939–2.906) 0.017 2.48(1.18–5.24)
Family cancer history 0.671 1.130(0.642–1.998)
AFP  < 0.001 2.619(1.489–4.607) 0.012 2.24(1.20–4.21)
Hepatitis B/C 0.088 0.614(0.351–1.075) 0.035 0.73(0.37–1.42)